Sienna Biopharmaceuticals (Sienna Biopharmaceuticals) EV-to-Revenue : (As of Jun. 05, 2024)

Sienna Biopharmaceuticals EV-to-Revenue Chart

Sienna Biopharmaceuticals Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
EV-to-Revenue	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Sienna Biopharmaceuticals's EV-to-Revenue

For the Biotechnology subindustry, Sienna Biopharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sienna Biopharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sienna Biopharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sienna Biopharmaceuticals's EV-to-Revenue falls into.

Sienna Biopharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sienna Biopharmaceuticals's EV-to-Revenue for today is calculated as:

Sienna Biopharmaceuticals's current Enterprise Value is $0.00 Mil.
Sienna Biopharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals  (OTCPK:SNNAQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sienna Biopharmaceuticals's PS Ratiofor today is calculated as:

Sienna Biopharmaceuticals's share price for today is $0.0001.
Sienna Biopharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sienna Biopharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sienna Biopharmaceuticals (Sienna Biopharmaceuticals) Business Description